These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 32888236)

  • 1. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An emerging role for cellular crosstalk in the cancer stem cell niche.
    Oshimori N; Guo Y; Taniguchi S
    J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression.
    Taniguchi S; Elhance A; Van Duzer A; Kumar S; Leitenberger JJ; Oshimori N
    Science; 2020 Jul; 369(6501):. PubMed ID: 32675345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
    Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
    Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling.
    Schober M; Fuchs E
    Proc Natl Acad Sci U S A; 2011 Jun; 108(26):10544-9. PubMed ID: 21670270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma.
    Zhao Y; Zhu J; Shi B; Wang X; Lu Q; Li C; Chen H
    J Exp Clin Cancer Res; 2019 Jul; 38(1):304. PubMed ID: 31296250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche.
    Rajayi H; Tavasolian P; Rezalotfi A; Ebrahimi M
    Int Rev Immunol; 2019; 38(6):267-283. PubMed ID: 31578892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.
    Huang H; Wang C; Liu F; Li HZ; Peng G; Gao X; Dong KQ; Wang HR; Kong DP; Qu M; Dai LH; Wang KJ; Zhou Z; Yang J; Yang ZY; Cheng YQ; Tian QQ; Liu D; Xu CL; Xu DF; Cui XG; Sun YH
    Clin Cancer Res; 2018 Sep; 24(18):4612-4626. PubMed ID: 29691294
    [No Abstract]   [Full Text] [Related]  

  • 12. An alginate-based platform for cancer stem cell research.
    Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
    Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of TGF-β Signaling on Cancer Cells and Cancer Stem Cells in the Bone Microenvironment.
    Futakuchi M; Lami K; Tachibana Y; Yamamoto Y; Furukawa M; Fukuoka J
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31619018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
    Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
    Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perivascular stem cell niche in head and neck cancer.
    Ritchie KE; Nör JE
    Cancer Lett; 2013 Sep; 338(1):41-6. PubMed ID: 22842095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms promoting physiological cells progression into tumorigenesis.
    Korbut E; Ptak-Belowska A; Brzozowski T
    J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Stem Cells in Squamous Cell Carcinoma.
    Jian Z; Strait A; Jimeno A; Wang XJ
    J Invest Dermatol; 2017 Jan; 137(1):31-37. PubMed ID: 27638386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.